957346-40-6 Usage
Molecular structure
1H-Isoindol-1-one, 7-fluoro-2,3-dihydro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)is a complex organic compound with a core structure of isoindole, which is a fused bicyclic ring system consisting of a six-membered benzene ring and a five-membered nitrogen-containing ring.
Fluorine atom
The presence of a fluorine atom in the compound suggests potential applications in medicinal chemistry, as fluorinated compounds are often used to enhance the bioactivity and pharmacokinetic properties of drug candidates.
Dihydro group
The compound contains a dihydro group (two hydrogen atoms) attached to the isoindole core, which may contribute to its chemical reactivity and stability.
Boron-containing ring system
The presence of a boron-containing ring system (1,3,2-dioxaborolan-2-yl) in the compound indicates that it may be used as a versatile building block for creating new molecules in organic synthesis or pharmaceutical research.
Tetramethyl substitution
The compound features a tetramethyl substitution (four methyl groups) on the dioxaborolan ring, which can influence its chemical properties and reactivity.
Potential applications
Due to its complex structure and functional groups, this chemical compound may be a valuable tool for creating new compounds with potential pharmacological or biological activities, particularly in the fields of organic synthesis and pharmaceutical research.
Check Digit Verification of cas no
The CAS Registry Mumber 957346-40-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,7,3,4 and 6 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 957346-40:
(8*9)+(7*5)+(6*7)+(5*3)+(4*4)+(3*6)+(2*4)+(1*0)=206
206 % 10 = 6
So 957346-40-6 is a valid CAS Registry Number.
957346-40-6Relevant articles and documents
TRIAZOLOPYRAZINE COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE & INFLAMMATORY DISEASES
-
, (2008/06/13)
Novel [1.2.4]triazolo[1,5-a]pyrazine compounds are disclosed that have a formula represented by the following (formula I). The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, arthritis, inflammation, and others.
